Peripheral vascular disease in diabetes

Principles of Diabetes Mellitus

Volumn , Issue , 2010, Pages 371-379

  Svahn, Jennifer K ^a   Kirk, Jeffrey S ^a   Llaguna, Omar H ^a   Habib, Nancy ^b  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892273381     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-09841-8_24     Document Type: Chapter

References (36)

1. Goldenburg SG, Alex M, Joshi RA, Blementhal HT. Nonatheromatous peripheral vascular disease of the lower extremity in diabetes mellitus. Diabetes. 1959;8:261-273.
2. Strandness DE Jr, Priest RE, Gibbons GE. Combine clinical and pathologic study of diabetic and nondiabetic peripheral arterial disease. Diabetes. 1964;13:366-372.
3. Conrad MC. Large and small artery occlusion in diabetics and nondiabetics with severe vascular disease. Circulation. 1967;36:83-91.
4. Bamer HB, Kaiser GC, William VL. Blood flow in the diabetic leg. Circulation. 1971;43:391-394.
5. Ernst CB, Stanley JC, Eds. Current Therapy in Vascular Surgery. 3rd Ed. St. Louis, MI: Mosby ; 1995.
6. Cohen RA. Dysfunction of vascular endothelium in diabetes mellitus. Circulation. 1993;87:67-76.
7. Parving HH, Viberti GC, Keen H, Christiansen JS, Lassen NA. Hemodynamic factors in genesis of diabetic microangiopathy. Metabolism. 1983;32:934-939.
8. Flynn MD, Tooke JE. Aetiology of diabetic ulceration: a role for the microcirculation? Diabetes Med. 1992;8: 320-329.
9. Rayman G, Williams SA, Spencer PD, et al. Impaired microvascularhyperemic response to minor skin trauma in type diabetes. Br Med J. 1986;292:1295-1298.
10. Parkhouse N, LeQueen PM. Impaired neurogenic vascular response in patients with diabetes and neuropathic foot lesions. N Engl J Med. 1998;318:1306-1309.
11. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373-376.
12. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biologic activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
13. Baron AD. The coupling of glucose metabolism and perfusion in the humanskeletal muscle. The potential role of endothelium-derived nitric oxide. Diabetes. 1996;45:S105-S109.
14. Wolff SP, Dean RT. Glucose autoxidation and protein modification: the role of oxidative glycosylation in diabetes. Biochem J. 1987;245:234-250.
15. Timimi FK, Ting HH, Haley EA, Roddy M, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol. 1998;31:552-557.
16. Moore WS. Vascular Surgery: A Comprehensive Review. 5th ed. Philadelphia, PA: W.B. Saunders co; 1997.
17. Eton D, Weaver F, Eds. Vascular Disease: A Multi-Specialty Approach to Diagnosis and Management. Austin, TX: Landes Bioscience; 1998.
18. Akbari CM, LoGerfo FW. Diabetes and peripheral vascular disease. J Vasc Surg. 1999;30:373-384.
19. LoGerfo FW, Gibbons GW, Pomposelli FB, et al. Trends in the care of the diabetic foot. Arch Surg. 1992;127:617-621.
20. Loscalzo J, Creager MA, Dzau VJ, Eds. Vascular, Medicine: A Textbook of Vascular Biology and Diseases. 2nd Edn. Boston: Little, Brown; 1996.
21. Baker WH, String ST, Hayes AC, Turner D. Diagnosis of peripheral occlusive disease: comparison of clinical evaluation and noninvasive laboratory. Arch Surg. 1978;113(11):1308-1310.
22. Akbari CM, Gibbons GW, Habershaw GM, et al. The effect of arterial reconstruction on the natural history of diabetic neuropathy. Arch Surg. 1997;132:148-152.
23. Gloviczki P, Bower TC, Toomey BJ, et al. Microscope-aided pedal bypass is an effective and low-risk operation to salvage the ischemic foot. Am J Surg. 1994;168(2):76-84.
24. Blonde L. State of diabetes care in the United States. Am J Manag Care. 2007 Apr;13(Suppl 2):S36-S40.
25. Driver VR, Madsen J, Goodman RA. Reducing amputation rates in patients with diabetes at a military medical center: the limb preservation service model. Diabetes Care. 2005 February 1;28(2):248-253.
26. Landmesser U, Hornig B, Drexler H. Endothelial function: a critical determinant in atherosclerosis? Circulation. 2004;109(Suppl 1):II27-II33.
27. Regensteiner JG, Wolfel EE, Brass Ep, et al. Chronic changes in skeletal muscle histology and function in peripheral arterial disease. Circulation 1993;87:413-421.
28. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003;26:3333-3341.
29. Muntner P, Wildman RP, Reynolds K, Desalvo KB, Chen J, Fonseca V. Relationship between HbA1c level and peripheral arterial disease. Diabetes Care. 2005;28:1981-1987.
30. Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med. 2004;141:421-431.
31. Criqui MH, Denenberg JO, Langer RD, Fronek A. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med. 1997;2:221-226.
32. Endovascular training program endorsement essentials. VascularWeb, 2007 [cited Dec 2007]
33. Prinssen M, Verhoeven EL, Buth J, et al. Dutch Randomized Endovascular Aneurysm Management (DREAM) Trial Group. A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. N Engl J Med. 2004;351:1607-1618.
34. de Virgilio C, Bui H, Donayre C, et al. Rodney white endovascular vs open abdominal aortic aneurysm repair: a comparison of cardiac morbidity and mortality. Arch Surg. 1999;134:947-951.
35. White CJ, Gray WA. Gray endovascular therapies for peripheral arterial disease: an evidence-based review. Circulation. 2007;116:2203-2215.
36. Current trials of interventions to prevent radiocontrast-induced nephropathy. Am J Ther. 2005 March/April;12(2):127-132.